Center-Authored Papers

Filters: Author is Sanchez, Jorge  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Zimbabwe
Fuchs J, Celum C, Wang J, Hughes JP, Sanchez J, Cowan F, Reid S, Delany-Moretlwe S, Corey L, Wald A.  2010.  Clinical and virologic efficacy of herpes simplex virus type 2 suppression by acyclovir in a multicontinent clinical trial.. The Journal of infectious diseases. 201(8):1164-8. Abstract
Zambia
Fuchs J, Celum C, Wang J, Hughes JP, Sanchez J, Cowan F, Reid S, Delany-Moretlwe S, Corey L, Wald A.  2010.  Clinical and virologic efficacy of herpes simplex virus type 2 suppression by acyclovir in a multicontinent clinical trial.. The Journal of infectious diseases. 201(8):1164-8. Abstract
Young Adult
Kim HN, Wang J, Hughes JP, Coombs R, Sanchez J, Reid S, Delany-Moretlwe S, Cowan F, Fuchs J, Eshleman SH et al..  2010.  Effect of acyclovir on HIV-1 set point among herpes simplex virus type 2-seropositive persons during early HIV-1 infection.. The Journal of infectious diseases. 202(5):734-8. Abstract
Guanira JV, Casper C, Lama JR, Morrow RA, Montano SM, Caballero P, Suárez L, Whittington WLH, Wald A, Sanchez J et al..  2008.  Prevalence and correlates of human herpesvirus 8 infection among Peruvian men who have sex with men.. Journal of acquired immune deficiency syndromes (1999). 49(5):557-62. Abstract
Jacob ST, Baeten JM, Hughes JP, Peinado J, Wang J, Sanchez J, Reid SE, Delany-Moretlwe S, Cowan F, Fuchs JD et al..  2011.  A post-trial assessment of factors influencing study drug adherence in a randomized biomedical HIV-1 prevention trial.. AIDS and behavior. 15(5):897-904. Abstract
Virus Shedding
Fuchs J, Celum C, Wang J, Hughes JP, Sanchez J, Cowan F, Reid S, Delany-Moretlwe S, Corey L, Wald A.  2010.  Clinical and virologic efficacy of herpes simplex virus type 2 suppression by acyclovir in a multicontinent clinical trial.. The Journal of infectious diseases. 201(8):1164-8. Abstract
Curlin ME, Huang M-L, Lu X, Celum CL, Sanchez J, Selke S, Baeten JM, Zuckerman RA, Erdman DD, Corey L.  2010.  Frequent detection of human adenovirus from the lower gastrointestinal tract in men who have sex with men.. PloS one. 5(6):e11321. Abstract
Viral Load
Kim HN, Wang J, Hughes JP, Coombs R, Sanchez J, Reid S, Delany-Moretlwe S, Cowan F, Fuchs J, Eshleman SH et al..  2010.  Effect of acyclovir on HIV-1 set point among herpes simplex virus type 2-seropositive persons during early HIV-1 infection.. The Journal of infectious diseases. 202(5):734-8. Abstract
Valine
Baeten JM, Lingappa J, Beck I, Frenkel LM, Pepper G, Celum C, Wald A, Fife KH, Were E, Mugo N et al..  2011.  Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons.. The Journal of infectious diseases. 203(1):117-21. Abstract
Vaccine and Infectious Disease Institute
Guanira JV, Casper C, Lama JR, Morrow RA, Montano SM, Caballero P, Suárez L, Whittington WLH, Wald A, Sanchez J et al..  2008.  Prevalence and correlates of human herpesvirus 8 infection among Peruvian men who have sex with men.. Journal of acquired immune deficiency syndromes (1999). 49(5):557-62. Abstract
Maclachlan E, Mayer KH, Barnabas R, Sanchez J, Koblin B, Duerr A.  2009.  The potential role of biomarkers in HIV preventive vaccine trials.. Journal of acquired immune deficiency syndromes (1999). 51(5):536-45. Abstract
Vaccine and Infectious Disease Division
Curlin ME, Huang M-L, Lu X, Celum CL, Sanchez J, Selke S, Baeten JM, Zuckerman RA, Erdman DD, Corey L.  2010.  Frequent detection of human adenovirus from the lower gastrointestinal tract in men who have sex with men.. PloS one. 5(6):e11321. Abstract
Goepfert PA, Elizaga ML, Seaton K, Tomaras GD, Montefiori DC, Sato A, Hural J, De Rosa SC, Kalams SA, McElrath MJ et al..  2014.  Specificity and 6-Month Durability of Immune Responses Induced by DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-Like Particles.. The Journal of infectious diseases. Abstract
Jacob ST, Baeten JM, Hughes JP, Peinado J, Wang J, Sanchez J, Reid SE, Delany-Moretlwe S, Cowan F, Fuchs JD et al..  2011.  A post-trial assessment of factors influencing study drug adherence in a randomized biomedical HIV-1 prevention trial.. AIDS and behavior. 15(5):897-904. Abstract
Baeten JM, Lingappa J, Beck I, Frenkel LM, Pepper G, Celum C, Wald A, Fife KH, Were E, Mugo N et al..  2011.  Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons.. The Journal of infectious diseases. 203(1):117-21. Abstract
Brockman MA, Chopera DR, Olvera A, Brumme CJ, Sela J, Markle TJ, Martin E, Carlson JM, Le AQ, McGovern R et al..  2012.  Uncommon Pathways of Immune Escape Attenuate HIV-1 Integrase Replication Capacity.. Journal of virology. 86(12):6913-23. Abstract
Duerr A, Huang Y, Buchbinder S, Coombs RW, Sanchez J, del Rio C, Casapia M, Santiago S, Huang Y, Gilbert P et al..  2013.  Reply to richie and villasante.. The Journal of infectious diseases. 207(4):690-2.
Fuchs J, Celum C, Wang J, Hughes JP, Sanchez J, Cowan F, Reid S, Delany-Moretlwe S, Corey L, Wald A.  2010.  Clinical and virologic efficacy of herpes simplex virus type 2 suppression by acyclovir in a multicontinent clinical trial.. The Journal of infectious diseases. 201(8):1164-8. Abstract
Nicholson O, Dicandilo F, Kublin J, Sun X, Quirk E, Miller M, Gray G, Pape J, Robertson MN, Mehrotra DV et al..  2011.  Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults.. AIDS research and human retroviruses. 27(5):557-567. Abstract
Duerr A, Huang Y, Buchbinder S, Coombs RW, Sanchez J, del Rio C, Casapia M, Santiago S, Gilbert P, Corey L et al..  2012.  Extended Follow-up Confirms Early Vaccine-Enhanced Risk of HIV Acquisition and Demonstrates Waning Effect Over Time Among Participants in a Randomized Trial of Recombinant Adenovirus HIV Vaccine (Step Study).. The Journal of infectious diseases. 206(2):258-266. Abstract
Kim HN, Wang J, Hughes JP, Coombs R, Sanchez J, Reid S, Delany-Moretlwe S, Cowan F, Fuchs J, Eshleman SH et al..  2010.  Effect of acyclovir on HIV-1 set point among herpes simplex virus type 2-seropositive persons during early HIV-1 infection.. The Journal of infectious diseases. 202(5):734-8. Abstract
United States
Fuchs J, Celum C, Wang J, Hughes JP, Sanchez J, Cowan F, Reid S, Delany-Moretlwe S, Corey L, Wald A.  2010.  Clinical and virologic efficacy of herpes simplex virus type 2 suppression by acyclovir in a multicontinent clinical trial.. The Journal of infectious diseases. 201(8):1164-8. Abstract
Baeten JM, Lingappa J, Beck I, Frenkel LM, Pepper G, Celum C, Wald A, Fife KH, Were E, Mugo N et al..  2011.  Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons.. The Journal of infectious diseases. 203(1):117-21. Abstract
Treatment Outcome
Kim HN, Wang J, Hughes JP, Coombs R, Sanchez J, Reid S, Delany-Moretlwe S, Cowan F, Fuchs J, Eshleman SH et al..  2010.  Effect of acyclovir on HIV-1 set point among herpes simplex virus type 2-seropositive persons during early HIV-1 infection.. The Journal of infectious diseases. 202(5):734-8. Abstract
Transgender Persons
Lemos MP, Lama JR, Karuna ST, Fong Y, Montano SM, Ganoza C, Gottardo R, Sanchez J, McElrath MJ.  2014.  The inner foreskin of healthy males at risk of HIV infection harbors epithelial CD4+ CCR5+ cells and has features of an inflamed epidermal barrier.. PloS one. 9(9):e108954. Abstract